Literature DB >> 17377037

Fat-containing nodules in the cirrhotic liver: chemical shift MRI features and clinical implications.

Jeong-Sik Yu1, Jae-Joon Chung, Joo Hee Kim, Ki Whang Kim.   

Abstract

OBJECTIVE: The purpose of this study was to determine the ability of MRI to predict malignancy in fat-containing nodules in the cirrhotic liver.
MATERIALS AND METHODS: In 38 patients with cirrhotic livers, focal lesions > or = 5 mm containing fatty components were identified on chemical shift gradient-echo MRI. Positive predictive values (PPVs) for benignity and malignancy were calculated on the basis of lesion size, T1-weighted hypointensity, T2-weighted hyperintensity, and arterial hypervascularity on the initial MR images. The number of the fatty nodules (group A, up to 4; group B, numerous) in individual patients was also correlated with the malignant potential of the lesions that were verified pathologically or by follow-up imaging studies.
RESULTS: In 31 group A patients, 21 (47%) of the 45 lesions showed a malignant course, and their mean diameter (18.8 mm) was larger (p = 0.007) than that (10.5 mm) of benign lesions. In seven group B patients, all 35 lesions (the five largest lesions in each patient; mean diameter, 7.8 mm) proved to be benign. The PPV of larger (> or = 15 mm) fat-containing nodules for malignancy was 85% (11/13 lesions). Six (55%) of 11 immediately diagnosed hepatocellular carcinomas were entirely hypointense on unenhanced in-phase T1-weighted images. The PPV of T2-weighted hyperintensity and arterial hypervascularity for the diagnosis of malignancy was 100% in group A patients.
CONCLUSION: In the cirrhotic liver, large size (> or = 15 mm) and T1-weighted hypointensity on in-phase images strongly suggest malignancy of the fat-containing nodules. The presence of numerous nodules < 1 cm suggests that the lesions are benign.

Entities:  

Mesh:

Year:  2007        PMID: 17377037     DOI: 10.2214/AJR.06.0756

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  12 in total

1.  Mapping of liver fat with triple-echo gradient echo imaging: validation against 3.0-T proton MR spectroscopy.

Authors:  Boris Guiu; Romaric Loffroy; Jean-Michel Petit; Serge Aho; Douraied Ben Salem; David Masson; Patrick Hillon; Jean-Pierre Cercueil; Denis Krause
Journal:  Eur Radiol       Date:  2009-02-27       Impact factor: 5.315

Review 2.  Magnetic resonance imaging of the cirrhotic liver: An update.

Authors:  Agnes Watanabe; Miguel Ramalho; Mamdoh AlObaidy; Hye Jin Kim; Fernanda G Velloni; Richard C Semelka
Journal:  World J Hepatol       Date:  2015-03-27

3.  Can modified LI-RADS increase the sensitivity of LI-RADS v2018 for the diagnosis of 10-19 mm hepatocellular carcinoma on gadoxetic acid-enhanced MRI?

Authors:  Sidong Xie; Yao Zhang; Jingbiao Chen; Ting Jiang; Weimin Liu; Dailin Rong; Lin Sun; Linqi Zhang; Bingjun He; Jin Wang
Journal:  Abdom Radiol (NY)       Date:  2021-11-13

4.  Identification of Imaging Predictors Discriminating Different Primary Liver Tumours in Patients with Chronic Liver Disease on Gadoxetic Acid-enhanced MRI: a Classification Tree Analysis.

Authors:  Hyun Jeong Park; Kyung Mi Jang; Tae Wook Kang; Kyoung Doo Song; Seong Hyun Kim; Young Kon Kim; Dong Ik Cha; Joungyoun Kim; Juna Goo
Journal:  Eur Radiol       Date:  2015-12-03       Impact factor: 5.315

Review 5.  MRI features of hepatocellular carcinoma related to biologic behavior.

Authors:  Eun-Suk Cho; Jin-Young Choi
Journal:  Korean J Radiol       Date:  2015-05-13       Impact factor: 3.500

Review 6.  Magnetic resonance imaging of the cirrhotic liver: diagnosis of hepatocellular carcinoma and evaluation of response to treatment - Part 1.

Authors:  Miguel Ramalho; António P Matos; Mamdoh AlObaidy; Fernanda Velloni; Ersan Altun; Richard C Semelka
Journal:  Radiol Bras       Date:  2017 Jan-Feb

Review 7.  Magnetic resonance imaging of the cirrhotic liver: diagnosis of hepatocellular carcinoma and evaluation of response to treatment - Part 2.

Authors:  Miguel Ramalho; António P Matos; Mamdoh AlObaidy; Fernanda Velloni; Ersan Altun; Richard C Semelka
Journal:  Radiol Bras       Date:  2017 Mar-Apr

Review 8.  Magnetic resonance imaging ancillary features used in Liver Imaging Reporting and Data System: An illustrative review.

Authors:  David Campos-Correia; João Cruz; António P Matos; Filipa Figueiredo; Miguel Ramalho
Journal:  World J Radiol       Date:  2018-02-28

9.  Utility of opposed-phase magnetic resonance imaging in differentiating sarcoma from benign bone lesions.

Authors:  Barry E Kenneally; Christina J Gutowski; Alan W Reynolds; William B Morrison; John A Abraham
Journal:  J Bone Oncol       Date:  2015-10-29       Impact factor: 4.072

Review 10.  Clinical utility of imaging for evaluation of hepatocellular carcinoma.

Authors:  Takamichi Murakami; Masakatsu Tsurusaki; Tomoko Hyodo; Yasuharu Imai
Journal:  J Hepatocell Carcinoma       Date:  2014-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.